Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
News
 
Pharma China Annual Forum 2019 (April 9, Shanghai) (free) 2/15/2019
Recent Official and Executive Moves 2/15/2019
NMPA Bans Compound Formulations Containing Furazolidone 2/15/2019
NHC Announces Plan for Nationwide Ad Hoc Regulatory Sample Inspec... 2/14/2019
CStone Kicks Off First Biotech IPO of 2019 on HKEx 2/14/2019
Burning Rock Completes Series C financing of CNY 850M (free) 2/14/2019
Sinohealth: Chinese Retail Pharmacy Sales Slowed to the Lowest Gr... 2/14/2019
CDE Seeks Comments on Four Draft Chinese Editions of ICH Guidelin... 2/13/2019
Ascletis and 3-V Biosciences Announce NASH Strategic License and ... 2/13/2019
CDE Publicizes Information on 62 Newly Approved GQCE Applications... 2/12/2019
CDE Publicizes Two More Drug Applications To Be Granted Priority ... 2/12/2019
More>>
 
Feature Articles
 
Highlights of the Draft 4th Amendment to the Chinese Patent Law 2/14/2019
China's Biotechnology Development: The Role of U.S. and Other For... 2/14/2019
Review of Chinese Pharma Deals, R&D and Regulatory Developments i... 2/13/2019
Chinese Pharma under Cloud Again in the Supposedly Lucky Year of ... 2/12/2019
SAMR Fines Hunan Er-Kang And Henan Jiushi CNY 10M for Unfair Pric... 2/8/2019
How a Tainted Heart Drug Made in China Slipped Past the FDA 1/30/2019
Implications on the Draft Amendment to the Drug Administration La... 1/29/2019
Ropes & Gary: China Aims To Introduce Routine Drug And Device Ove... 1/22/2019
China Pharma Must Swallow That Jagged Little Pill Called R&D as G... 1/21/2019
China's Patent Flood Stifles Foreign Filer Freedom 1/17/2019
China's Biopharmas Buffeted by Clashing Market Dynamics 1/16/2019
More>>
 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links